The overexpression of HNRNPK was associated with neuroblastoma progression (Li et al., 2018), while downregulation of HNRNPK repressed glioblastoma cell proliferation and induced apoptosis (Wu et al., 2020). The gene discussed is HNRNPK; the disease is glioblastoma.